Memphasys Ltd has released a press release.
Equine study commences with 12mth commercialisation expected
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Prospectus
- Short term loan facility
- Positive initial study results - Felix equine application
- Reinstatement to Official Quotation
- A$2 million capital raising
Later from Memphasys
- Felix Trial registration update
- MEM Investor Presentation
- Completion of Placement and SPP offer
- RoXsta System Secures Provisional Patent Approval
- Felix Clinical Trial Reaches 95% Completion
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys